BPG is committed to discovery and dissemination of knowledge
            
            
                
                
                    
    Articles Published Processes
    
        11/7/2024 8:48:05 AM | Browse: 90 | Download: 526
    
    
        
        
    
        | 
                
                    |  | Received |  | 2024-07-26 16:18 | 
    
        | 
                
                    |  | Peer-Review Started |  | 2024-07-26 16:18 | 
    
        | 
                
                    |  | To Make the First Decision |  |  | 
    
        | 
                
                    |  | Return for Revision |  | 2024-08-18 20:52 | 
    
        | 
                
                    |  | Revised |  | 2024-08-26 11:20 | 
    
        | 
                
                    |  | Second Decision |  | 2024-09-19 02:45 | 
    
        | 
                
                    |  | Accepted by Journal Editor-in-Chief |  |  | 
    
        | 
                
                    |  | Accepted by Executive Editor-in-Chief |  | 2024-09-19 13:30 | 
    
        | 
                
                    |  | Articles in Press |  | 2024-09-19 13:30 | 
    
        | 
                
                    |  | Publication Fee Transferred |  |  | 
    
        | 
                
                    |  | Edit the Manuscript by Language Editor |  |  | 
    
        | 
                
                    |  | Typeset the Manuscript |  | 2024-09-25 02:30 | 
            
                | 
                        
                            |  | Publish the Manuscript Online |  | 2024-11-07 08:48 | 
        
        
            
                | ISSN | 2220-6124 (online) | 
            
                | Open Access | This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ | 
            
                | Copyright | © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. | 
                    
                        | Article Reprints | For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247 | 
            
            
                | Permissions | For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207 | 
            
            
                | Publisher | Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | 
            
                | Website | http://www.wjgnet.com | 
        
    
        | Category | Urology & Nephrology | 
    
        | Manuscript Type | Retrospective Cohort Study | 
    
        | Article Title | Adult minimal change disease: Clinicopathologic characteristics, treatment response and outcome at a single center in Pakistan | 
    
        | Manuscript Source | Invited Manuscript | 
    
        | All Author List | Shaheera Shakeel, Rahma Rashid, Nazarul H Jafry and Muhammed Mubarak | 
            
                | ORCID |  | 
    
        | Funding Agency and Grant Number |  | 
    
        | Corresponding Author | Muhammed Mubarak, FCPS, Professor, Department of Histopathology, Sindh Institute of Urology and Transplantation, Chand Bibi Road, Karachi 74200, Sindh, Pakistan. drmubaraksiut@yahoo.com | 
    
        | Key Words | Minimal change disease; Nephrotic syndrome; Adults; Steroid therapy; Immunosuppression; Clinical outcomes; Pakistan | 
    
        | Core Tip | Minimal change disease (MCD) constitutes the third most common cause of nephrotic syndrome in adults. The information is scanty on the clinicopathological features, treatment responses, and long-term outcomes of MCD in adults, particularly from developing countries. This study revealed that MCD in adults shows a favorable response to steroid therapy, with a majority achieving remission. However, relapses are common, necessitating second-line immunosuppressive treatments in some cases. The study highlights the need for standardized treatment guidelines for adult MCD to optimize outcomes. | 
            
                | Publish Date | 2024-11-07 08:48 | 
    
        | Citation | <p>Shakeel S, Rashid R, Jafry NH, Mubarak M. Adult minimal change disease: Clinicopathologic characteristics, treatment response and outcome at a single center in Pakistan. <i>World J Nephrol</i> 2024; 13(4): 99643</p> | 
            
                | URL | https://www.wjgnet.com/2220-6124/full/v13/i4/99643.htm | 
            
                | DOI | https://dx.doi.org/10.5527/wjn.v13.i4.99643 | 
    
    
        
                
        
     
 
                 
             
         
        
    
        
        
            © 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
            California Corporate Number: 3537345